Abstract:
Thus, in patients with isolated middleaged
and elderly systolic hypertension,
antihypertensive monotherapy with lercanidipine
has a comparable antihypertensive effect, leads
to normalization of the daily blood pressure
profile with the achievement of the target level
of systolic blood pressure in 73.3 and 75% of
patients, respectively.
